Catalyst Wire Dossier Catalyst Wire Dossier

Lamprene

clofazimine · Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lamprene, covering 2025-12-05 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB [Phase 2]

See pricing